Company profileCore BCI
Paradromics
A high-data-rate intracortical BCI aimed first at restoring speech.
- Location
- Austin, United States
- Founded
- 2015
- Class
- Core BCI
- Website
- paradromics.com
- Sources last checked
- 3 Oct 2026
What they are building
Builds the Connexus BCI, a fully implanted system that records from individual neurons through arrays of fine microwire electrodes.
- Interface category
- Intracortical arrays
- Signal
- Action potentials and local field potentials
- Invasiveness
- Invasive
- Recording / stimulation
- Recording
- Device
- Connexus BCI — Implanted cortical module of microwire electrodes linked to a chest-mounted transceiver
- Regulatory status
- Investigational; early feasibility study under FDA IDE
- Main use cases
- Communicate, Control
- Works with
- University of Michigan
Where they are clinically
Feasibility
Small early studies that test safety and whether the device can do what it is meant to.
Access today
Clinical study
Accessible only by enrolling in a registered clinical study.
- Shown in people
- One long-term implant, in June 2026. The company says the participant produced real-time speech and text, and has published neither accuracy nor rate.
- Still an aim
- Speech at the level of the academic intracortical systems, whose best published case is 97.5% word accuracy, from a fully implanted device.
- What stands in the way
- Numbers: Connect-One plans two participants and nothing quantitative has been released.
On record here: 1 registered study · 2 participants planned or enrolled · 0 peer-reviewed papers
This technology remains experimental and is not an established treatment. Access is limited to registered clinical studies.
- Nov 2025US FDA — Investigational device exemption. Permits a clinical study of an investigational device. Not a marketing authorisation.
Why this company matters
Paradromics entered the clinic later than its peers but with speech as the first indication, the application where academic intracortical results are strongest. Its September announcement is encouraging and unquantified: no accuracy or rate figures were released. Published metrics from Connect-One will show how a commercial system compares with the academic speech benchmarks.
Key milestones
14 Sep 2026
Company reports that its first participant used the system for real-time speech and text of her own choosing.
17 Jun 2026
First long-term Connexus implant, at University of Michigan Health.
31 Mar 2026
Connect-One begins; three sites listed, two participants planned.
Nov 2025
FDA authorises the Connect-One early feasibility study under an investigational device exemption.
Clinical programmes
- Connect-One
First long-term human study of the Connexus BCI, focused on speech.
FeasibilityRecruiting
2 estimatedNCT07357428
Leadership
Matt Angle
Founder and CEO
As publicly stated by the organisation. Not a complete list.
IP and patents
Filings spread across 6 of the 11 layers, most often interface and electrodes (12 of 13 families) and packaging (6).
- 13
- patent families identified and counted as BCI
- 2016
- earliest first filing among them
- 4
- first filed since 2021; the latest years are incomplete
- 10 of 13
- include a granted member, of those whose family record was read
Across the stack: families by layer
Themes, by number of families: electrodes and arrays (12), connectors and feedthroughs (4), packaging and hermeticity (3), wireless telemetry (3), signal processing (3), insertion tools and robots (2). A family can carry several.
Published in: United States (13), China (1), counted over the 13 families whose full record was read.
Representative families
- Systems, devices, and methods for tissue layer removalfirst filed 2019Granted · US
- Low-area, low-power neural recording circuit, and method of training the samefirst filed 2017 · Electrodes and arrays, Signal acquisition, Signal processingGranted · US
- Patterned microwire bundles and methods of producing the samefirst filed 2017 · Electrodes and arrays, Connectors and feedthroughs, Wireless telemetryGranted · US
- Systems and methods for detecting corrupt or inaccurate sensory representationsfirst filed 2016 · Electrodes and arrays, Signal processing, Neural decodingGranted · US
- System and methods for processing neural signalsfirst filed 2016 · Electrodes and arrays, Peripheral interfaces, Signal processingGranted · US
- Neural-interface probe and methods of packaging the samefirst filed 2016 · Electrodes and arrays, Chips and on-implant computing, Packaging and hermeticityGranted · US
7 more families counted
- Systems, devices, and methods for inserting arraysfirst filed 2023 · Insertion tools and robots, Electrodes and arrays, Packaging and hermeticityGranted · US
- Cranial hub, systems and methods of using samefirst filed 2022 · Electrodes and arrays, Packaging and hermeticity, Wireless telemetryApplication
- Systems and methods for manufacturing needle array electrodesfirst filed 2022 · Insertion tools and robots, Electrodes and arrays, Connectors and feedthroughsGranted · US
- Methods for improved biocompatibility for human implanted medical devicesfirst filed 2021 · Electrodes and arrays, Implant electronicsGranted · US
- Microelectrode array and methods of fabricating samefirst filed 2019 · Electrodes and arrays, Chips and on-implant computing, Connectors and feedthroughsApplication
- Systems And Methods For Splaying Microelectrode Sensorsfirst filed 2016 · Electrodes and arraysApplication
- Systems and methods for testing conductive microwirefirst filed 2016 · Electrodes and arraysGranted · US
Families found for Paradromics in the EPO’s worldwide database, grouped so that one invention counts once. A filing shows what a company sought to protect. It does not show that the technology was built, is in a product, or works in people, and themes are read from titles, abstracts and classes, not from the claims. How to read this
Competitive context
IntracorticalFeasibility
Neuralink
A fully implanted, wireless intracortical BCI placed by a surgical robot.
IntracorticalFeasibility
Blackrock Neurotech
Maker of the electrode arrays behind most human intracortical BCI research.
ECoGApproved / cleared
Precision Neuroscience
A thin-film cortical surface array that slides under the skull through a narrow slit.
Latest BCI Briefing coverage
Clinical · 14 Sep 2026
Paradromics reports real-time speech from its first study participantDossier Nº 01
The State of Speech BCIs
Sources
- 01
Paradromics Achieves Real-Time Speech with Connexus Brain-Computer Interface (opens in a new tab)
Company reportedParadromics press release (via BioSpace)14 Sep 2026Checked against source 3 Oct 2026
Press release. Contains no quantitative performance figures and no peer-reviewed data.
- 02
Paradromics completes first implant in BCI early feasibility study (opens in a new tab)
Independent reportingMassDevice17 Jun 2026Source identified, not opened
- 03
ClinicalTrials.gov NCT07357428 (opens in a new tab)
Clinical registryClinicalTrials.gov14 Apr 2026Checked against source 3 Oct 2026
Registry record last updated 2026-04-14.